These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 24342929)

  • 1. Apparently "low" serum asymmetric dimethylarginine is associated with fasting glucose and tends toward association with type-2 diabetes.
    Onat A; Köroğlu B; Can G; Karagöz A; Yüksel M; Aydın M
    Anadolu Kardiyol Derg; 2014 Feb; 14(1):26-33. PubMed ID: 24342929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADMA is a correlate of insulin resistance in early-stage diabetes independent of hs-CRP and body adiposity.
    Nakhjavani M; Karimi-Jafari H; Esteghamati A; Khalilzadeh O; Asgarani F; Ghadiri-Anari A
    Ann Endocrinol (Paris); 2010 Sep; 71(4):303-8. PubMed ID: 20434720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum complement C3: a determinant of cardiometabolic risk, additive to the metabolic syndrome, in middle-aged population.
    Onat A; Hergenç G; Can G; Kaya Z; Yüksel H
    Metabolism; 2010 May; 59(5):628-34. PubMed ID: 19913840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum total and high-density lipoprotein phospholipids: independent predictive value for cardiometabolic risk.
    Onat A; Altuğ Çakmak H; Can G; Yüksel M; Köroğlu B; Yüksel H
    Clin Nutr; 2014 Oct; 33(5):815-22. PubMed ID: 24246837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between serum asymmetric dimethylarginine levels and subjective sleep quality in normotensive patients with type 2 diabetes mellitus.
    Aribas A; Kayrak M; Tekinalp M; Akilli H; Alibasic H; Yildirim S; Gunduz M; Taner A; Unlu A
    Korean J Intern Med; 2015 May; 30(3):316-24. PubMed ID: 25995662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asymmetric dimethylarginine is associated with macrovascular disease and total homocysteine in patients with type 2 diabetes.
    Krzyzanowska K; Mittermayer F; Krugluger W; Schnack C; Hofer M; Wolzt M; Schernthaner G
    Atherosclerosis; 2006 Nov; 189(1):236-40. PubMed ID: 16414052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asymmetric dimethylarginine association with antioxidants intake in healthy young adults: a role as an indicator of metabolic syndrome features.
    Puchau B; Zulet MA; Urtiaga G; Navarro-Blasco I; Martínez JA
    Metabolism; 2009 Oct; 58(10):1483-8. PubMed ID: 19586644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum asymmetric dimethylarginine levels among Turks: association with metabolic syndrome in women and tendency to decrease in smokers.
    Onat A; Hergenç G; Can G; Karabulut A
    Turk Kardiyol Dern Ars; 2008 Jan; 36(1):7-13. PubMed ID: 18453780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired anti-inflammatory function of apolipoprotein A-II concentrations predicts metabolic syndrome and diabetes at 4 years follow-up in elderly Turks.
    Onat A; Hergenç G; Ayhan E; Uğur M; Can G
    Clin Chem Lab Med; 2009; 47(11):1389-94. PubMed ID: 19817643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum asymmetric dimethylarginine and arginine levels predict microvascular and macrovascular complications in type 2 diabetes mellitus.
    Ganz T; Wainstein J; Gilad S; Limor R; Boaz M; Stern N
    Diabetes Metab Res Rev; 2017 Feb; 33(2):. PubMed ID: 27393712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of circulating dimethylarginines with the metabolic syndrome in the Framingham Offspring study.
    Yola IM; Moser C; Duncan MS; Schwedhelm E; Atzler D; Maas R; Hannemann J; Böger RH; Vasan RS; Xanthakis V
    PLoS One; 2021; 16(9):e0254577. PubMed ID: 34492019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum γ-glutamyltransferase: independent predictor of risk of diabetes, hypertension, metabolic syndrome, and coronary disease.
    Onat A; Can G; Örnek E; Çiçek G; Ayhan E; Doğan Y
    Obesity (Silver Spring); 2012 Apr; 20(4):842-8. PubMed ID: 21633402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asymmetric dimethylarginine, cortisol/cortisone ratio, and C-peptide: markers for diabetes and cardiovascular risk?
    Anderson JL; Carlquist JF; Roberts WL; Horne BD; May HT; Schwarz EL; Pasquali M; Nielson R; Kushnir MM; Rockwood AL; Bair TL; Muhlestein JB;
    Am Heart J; 2007 Jan; 153(1):67-73. PubMed ID: 17174641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fasting, non-fasting glucose and HDL dysfunction in risk of pre-diabetes, diabetes, and coronary disease in non-diabetic adults.
    Onat A; Can G; Çiçek G; Ayhan E; Doğan Y; Kaya H
    Acta Diabetol; 2013 Aug; 50(4):519-28. PubMed ID: 21769500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pioglitazone decreases asymmetric dimethylarginine levels in patients with impaired glucose tolerance or type 2 diabetes.
    Tahara N; Yamagishi S; Mizoguchi M; Tahara A; Imaizumi T
    Rejuvenation Res; 2013 Oct; 16(5):344-51. PubMed ID: 23777507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of serum asymmetric dimethylarginine levels for the determination of masked hypertension in patients with diabetes mellitus.
    Taner A; Unlu A; Kayrak M; Tekinalp M; Ayhan SS; Arıbaş A; Erdem SS
    Atherosclerosis; 2013 Jun; 228(2):432-7. PubMed ID: 23540293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum creatinine is associated with coronary disease risk even in the absence of metabolic disorders.
    Onat A; Yüksel H; Can G; Köroğlu B; Kaya A; Altay S
    Scand J Clin Lab Invest; 2013 Oct; 73(7):569-75. PubMed ID: 24094290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated concentrations of asymmetric dimethylarginine are associated with deterioration of glucose tolerance in women with previous gestational diabetes mellitus.
    Mittermayer F; Kautzky-Willer A; Winzer C; Krzyzanowska K; Prikoszovich T; Demehri S; Wagner O; Wolzt M
    J Intern Med; 2007 Apr; 261(4):392-8. PubMed ID: 17391114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum uric acid is a determinant of metabolic syndrome in a population-based study.
    Onat A; Uyarel H; Hergenç G; Karabulut A; Albayrak S; Sari I; Yazici M; Keleş I
    Am J Hypertens; 2006 Oct; 19(10):1055-62. PubMed ID: 17027827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of nebivolol and metoprolol treatments on serum asymmetric dimethylarginine levels in hypertensive patients with type 2 diabetes mellitus.
    Oğuz A; Uzunlulu M; Yorulmaz E; Yalçin Y; Hekim N; Fici F
    Anadolu Kardiyol Derg; 2007 Dec; 7(4):383-7. PubMed ID: 18065333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.